Related Experiment Video
Updated: Jan 20, 2026

Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
Published on: August 4, 2011
Biologic Agents and Secondary Immune Deficiency
Heather Axelrod1, Matthew Adams2
1Department of Pediatrics (PGY3), Children's Hospital of Michigan, Detroit, MI, USA.
Biologics, protein-based drugs from living sources, are analyzed for immune suppression effects. The review highlights data gaps in pediatric populations, particularly in rheumatology.
Area of Science:
- Pharmacology
- Immunology
- Pediatric Medicine
Background:
- Biologics are protein-based therapeutics derived from biological sources.
- Their use in treating various conditions, especially autoimmune diseases, has grown significantly.
- Understanding their immunomodulatory effects is crucial for safe and effective treatment.
Purpose of the Study:
- To review the mechanism of action of approved biologics.
- To summarize existing research on the immunomodulatory effects of biologics.
- To evaluate the relevance of current data for pediatric populations and identify knowledge gaps.
Main Methods:
- Literature review of approved biologics.
- Analysis of studies focusing on immune suppression induced by biologics.
- Examination of existing data specifically for pediatric rheumatology patients.
Main Results:
- Biologics function through diverse mechanisms targeting specific immune pathways.
- Most available data on biologic-induced immune suppression comes from adult rheumatology studies.
- Significant gaps exist in understanding the long-term immunomodulatory effects and safety of biologics in children.
Conclusions:
- Biologics represent a critical therapeutic class with complex immunomodulatory actions.
- Current research predominantly focuses on adult populations, limiting direct applicability to pediatric care.
- Further targeted research is essential to address the unique immunological profiles and treatment needs of children.
More Related Videos
07:56Methods for Rearing the Parasitoid Ganaspis brasiliensis, a Promising Biological Control Agent for the Invasive Drosophila suzukii
Published on: June 2, 2022
11:27Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
Related Concept Videos
07:55Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
What is the Immune System?
Secondary Active Transport
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Secondary Healthcare System
Primary and Secondary Growth in Roots and Shoots